PROCEPT BioRobotics Jumps 30% Today on Massive Revenue Surge $PRCT #stocks #investing #valueinvesting # https://t.co/DiRRcnyzNl
📈 FSMN MARKET MOVERS 📉 Top Gainers • Revance Therapeutics $RVNC Up 29.29% To $6.08 • Monte Rosa Therapeutics $GLUE Up 29.24% To $6.32 • PROCEPT BioRobotics $PRCT Up 23.6% To $85.00 • Vera Therapeutics $VERA Up 14.91% To $47.22 • WeRide $WRD Up 13.69% To $18.82 • Fitell…
$PRCT (+14.9% pre) Procept Biorobotics Shares Rise on Narrowed Loss, Raised Guidance - MW https://t.co/io0JjzA6nZ

PROCEPT BioRobotics reported a total revenue of $58.4 million for the third quarter of 2024, marking a 66% increase compared to the same period in 2023. The company's U.S. handpiece and consumables revenue reached $29.6 million, reflecting a 74% year-over-year growth. Following the announcement, PROCEPT BioRobotics shares surged by 23.6%, trading at $85.00. The company also raised its revenue and adjusted EBITDA guidance for the full year 2024, contributing to a positive market reaction, with shares rising by as much as 30% during the trading day.